查看購物車
  • Simplified Chinese
  • English
  • Japanese
  • Korean
封面
市場調查報告書
商品編碼
1573009

血液 DNA套件市場：按技術、最終用戶分類 - 2025-2030 年全球預測

Blood DNA Kit Market by Technology (Next-Generation Sequencing, Polymerase Chain Reaction), End User (Hospital and Clinics, Research Centers) - Global Forecast 2025-2030
出版日期: | 出版商: 360iResearch | 英文 190 Pages | 商品交期: 最快1-2個工作天內

價格

※ 本網頁內容可能與最新版本有所差異。詳細情況請與我們聯繫。

血液 DNA套件市場價值 2023 年為 8.6736 億美元，預計到 2024 年將達到 9.3638 億美元，複合年成長率為 6.48%，到 2030 年將達到 13.4673 億美元。

血液 DNA套件市場的範圍和定義包括為基因檢測、法醫學和健康診斷而設計的各種產品。這些套件有助於從血液樣本中提取和分析 DNA，並在精準醫療、譜系測試和個人化治療策略中發揮重要作用。隨著基因組學和生物技術的進步，對個人化醫療和疾病早期檢測的需求不斷成長，從而推動了對血液 DNA套件的需求。這些套件對於多種應用至關重要，包括遺傳疾病診斷、藥物基因組學和腫瘤學研究。最終使用領域包括醫療機構、法醫學實驗室、研究機構等。市場成長受到遺傳疾病診斷意識增強、政府對基因組計劃的支持以及提高 DNA 分析準確性和速度的技術進步等因素的影響。在醫療保健基礎設施不斷發展的新興市場中，成長機會顯而易見。公司可以透過擴大分銷網路和開發適合當地需求的經濟高效的套件來利用這些機會。然而，擴大市場也帶來了挑戰，包括先進套件的高成本、圍繞基因資料隱私的道德問題以及可能延遲產品核可的嚴格法規結構。產業公司必須專注於非侵入式測試方法和自動化的創新，以降低成本並改善使用者體驗。持續的研發投入可以帶來多標靶檢測套組的突破，進而拓寬應用範圍。市場競爭激烈，併購是取得競爭優勢的常見策略。因此，企業應探索與醫療保健提供者和研究機構的策略聯盟和研究合作，以最佳化銷售管道並增加其市場佔有率。透過主動解決資料隱私問題並適應監管標準，公司可以有效應對市場挑戰。

主要市場統計
基準年[2023] 8.6736 億美元
預測年份 [2024] 93638萬美元
預測年份 [2030] 13.4673 億美元
複合年成長率（%） 6.48%

市場動態：揭示快速發展的血液 DNA套件市場的關鍵市場洞察

供需的動態交互作用正在改變血液 DNA套件市場。了解這些不斷變化的市場動態可以幫助企業做出明智的投資決策、策略決策並抓住新的商機。全面了解這些趨勢可以幫助企業降低政治、地理、技術、社會和經濟領域的風險，同時消費行為及其對製造成本的影響以及對採購趨勢的影響。

  • 市場促進因素
    • 臨床實驗室擴大採用血液 DNA套件進行診斷
    • 透過基因組學和相關技術的進步提高血液 DNA套件的準確性
    • 需要早期診斷的遺傳疾病和慢性病盛行率上升
    • 對個人化醫療的需求不斷成長，推動了對高效 DNA檢測套組的需求
  • 市場限制因素
    • 對高度專業化設備和熟練人員的需求增加了血液 DNA套件製造商的營運成本
  • 市場機會
    • 遺傳疾病和癌症盛行率的上升促使人們採用血液 DNA檢測套組。
    • 預防保健意識的增強促使消費者使用血液 DNA套件
    • 由於血液 DNA 檢測在祖先和系譜研究中的廣泛使用，市場需求增加
  • 市場挑戰
    • 樣本品質和採集方法的變化可能導致測試結果不一致且不可靠，進而影響市場成長。

波特五力：駕馭血液 DNA套件市場的策略工具

波特的五力框架是理解市場競爭格局的重要工具。波特的五力框架為評估公司的競爭地位和探索策略機會提供了清晰的方法。該框架可幫助公司評估市場動態並確定新業務的盈利。這些見解使公司能夠利用自己的優勢，解決弱點並避免潛在的挑戰，從而確保更強大的市場地位。

PESTLE分析：了解血液 DNA套件市場的外部影響

外部宏觀環境因素在塑造血液 DNA套件市場的績效動態方面發揮著至關重要的作用。對政治、經濟、社會、技術、法律和環境因素的分析提供了應對這些影響所需的資訊。透過調查 PESTLE 因素，公司可以更了解潛在的風險和機會。這種分析可以幫助公司預測法規、消費者偏好和經濟趨勢的變化，並幫助他們做出積極主動的決策。

市場佔有率分析 了解血液 DNA套件市場的競爭狀況

血液 DNA套件市場的詳細市場佔有率分析可以對供應商的績效進行全面評估。公司可以透過比較收益、客戶群和成長率等關鍵指標來揭示其競爭地位。該分析揭示了市場集中、分散和整合的趨勢，為供應商提供了製定策略決策所需的洞察力，使他們能夠在日益激烈的競爭中佔有一席之地。

FPNV 定位矩陣血液 DNA套件市場供應商的績效評估

FPNV 定位矩陣是評估血液 DNA套件市場供應商的重要工具。此矩陣允許業務組織根據商務策略和產品滿意度評估供應商，從而做出與其目標相符的明智決策。這四個象限使您能夠清晰、準確地分類供應商，以確定最能滿足您的策略目標的合作夥伴和解決方案。

制定血液 DNA套件市場成功之路的策略分析與建議

血液 DNA套件市場的策略分析對於旨在加強其在全球市場的影響力的公司至關重要。透過考慮關鍵資源、能力和績效指標，公司可以識別成長機會並努力改進。這種方法使您能夠克服競爭環境中的挑戰，利用新的商機並取得長期成功。

本報告對市場進行了全面分析，涵蓋關鍵重點領域：

1. 市場滲透率：詳細檢視當前市場環境、主要企業的廣泛資料、評估其在市場中的影響力和整體影響力。

2. 市場開拓：辨識新興市場的成長機會，評估現有領域的擴張潛力，並提供未來成長的策略藍圖。

3. 市場多元化：分析近期產品發布、開拓地區、關鍵產業進展、塑造市場的策略投資。

4. 競爭評估與情報：徹底分析競爭格局，檢驗市場佔有率、業務策略、產品系列、認證、監理核准、專利趨勢、主要企業的技術進步等。

5. 產品開發與創新：重點在於有望推動未來市場成長的最尖端科技、研發活動和產品創新。

我們也回答重要問題，以幫助相關人員做出明智的決策：

1.目前的市場規模和未來的成長預測是多少？

2. 哪些產品、區隔市場和地區提供最佳投資機會？

3.塑造市場的主要技術趨勢和監管影響是什麼？

4.主要廠商的市場佔有率和競爭地位如何？

5. 推動供應商市場進入和退出策略的收益來源和策略機會是什麼？

目錄

第1章 前言

第2章調查方法

第3章執行摘要

第4章市場概況

第5章市場洞察

  • 市場動態
    • 促進因素
      • 臨床實驗室擴大採用血液 DNA套件進行診斷
      • 基因組學和相關技術的進步提高了血液 DNA套件的準確性
      • 需要早期診斷的遺傳疾病和慢性病增加
      • 對個人化醫療的需求不斷成長，增加了對高效 DNA檢測套組的需求
    • 抑制因素
      • 對高度專業化的設備和熟練人員的需求增加了血液 DNA套件製造商的營運成本。
    • 機會
      • 遺傳疾病和癌症發生率的上升推動了血液 DNA套件的推出
      • 預防保健意識的提高促使消費者使用血液 DNA套件
      • 血液DNA檢測在血統和家譜研究的應用擴大，市場需求增加
    • 任務
      • 樣本品質和採集方法的變化可能導致測試結果不一致且不可靠，進而影響市場成長。
  • 市場區隔分析
  • 波特五力分析
  • PESTEL分析
    • 政治的
    • 經濟
    • 社群
    • 技術的
    • 合法地
    • 環境

第6章血液 DNA套件市場：依技術分類

  • 次世代定序
  • 聚合酵素鏈鎖反應

第7章 血液 DNA套件市場：依最終用戶分類

  • 醫院和診所
  • 研究中心

第8章北美及南美血液DNA套件市場

  • 阿根廷
  • 巴西
  • 加拿大
  • 墨西哥
  • 美國

第9章亞太血液DNA套件市場

  • 澳洲
  • 中國
  • 印度
  • 印尼
  • 日本
  • 馬來西亞
  • 菲律賓
  • 新加坡
  • 韓國
  • 台灣
  • 泰國
  • 越南

第10章 歐洲、中東和非洲血液DNA套件市場

  • 丹麥
  • 埃及
  • 芬蘭
  • 法國
  • 德國
  • 以色列
  • 義大利
  • 荷蘭
  • 奈及利亞
  • 挪威
  • 波蘭
  • 卡達
  • 俄羅斯
  • 沙烏地阿拉伯
  • 南非
  • 西班牙
  • 瑞典
  • 瑞士
  • 土耳其
  • 阿拉伯聯合大公國
  • 英國

第11章競爭格局

  • 2023 年市場佔有率分析
  • FPNV 定位矩陣，2023
  • 競爭情境分析
  • 戰略分析和建議
Product Code: MRR-2B5802CFEA27

The Blood DNA Kit Market was valued at USD 867.36 million in 2023, expected to reach USD 936.38 million in 2024, and is projected to grow at a CAGR of 6.48%, to USD 1,346.73 million by 2030.

The scope and definition of the Blood DNA Kit market encompass a range of products designed for genetic testing, forensics, and health diagnostics. These kits facilitate the extraction and analysis of DNA from blood samples, playing a critical role in precision medicine, ancestry testing, and personalized treatment strategies. The necessity for blood DNA kits is driven by the increasing demand for personalized medicine and early disease detection, heightened by advancements in genomics and biotechnology. These kits are crucial in various applications such as genetic disorder diagnosis, pharmacogenomics, and oncology research. End-use sectors include healthcare institutions, forensic laboratories, and research organizations. Market growth is influenced by factors such as rising awareness about genetic disease diagnosis, government support for genomic projects, and advancements in technology that enhance accuracy and speed of DNA analysis. Opportunities for growth are evident in emerging markets where healthcare infrastructure is evolving. Companies can capitalize on these opportunities by expanding distribution networks and developing cost-effective kits tailored to local needs. However, market expansion faces challenges such as high costs of advanced kits, ethical concerns surrounding genetic data privacy, and stringent regulatory frameworks that may delay product approvals. Industry players need to focus on innovations in non-invasive testing methods and automation to reduce costs and enhance user experience. Continued investment in research and development can lead to breakthroughs in multi-target testing kits, thereby broadening application scope. The nature of the market is highly competitive, with mergers and acquisitions being common strategies for gaining a competitive edge. Therefore, companies should explore strategic partnerships and collaborations with healthcare providers and research institutions to optimize distribution channels and strengthen market presence. By proactively addressing data privacy concerns and adapting to regulatory standards, businesses can effectively navigate market challenges.

KEY MARKET STATISTICS
Base Year [2023] USD 867.36 million
Estimated Year [2024] USD 936.38 million
Forecast Year [2030] USD 1,346.73 million
CAGR (%) 6.48%

Market Dynamics: Unveiling Key Market Insights in the Rapidly Evolving Blood DNA Kit Market

The Blood DNA Kit Market is undergoing transformative changes driven by a dynamic interplay of supply and demand factors. Understanding these evolving market dynamics prepares business organizations to make informed investment decisions, refine strategic decisions, and seize new opportunities. By gaining a comprehensive view of these trends, business organizations can mitigate various risks across political, geographic, technical, social, and economic domains while also gaining a clearer understanding of consumer behavior and its impact on manufacturing costs and purchasing trends.

  • Market Drivers
    • Increased adoption of blood DNA kits by clinical laboratories for diagnostic purposes
    • Advancements in genomics and related technologies enhancing blood DNA kit accuracy
    • Rising prevalence of genetic disorders and chronic diseases necessitating early diagnosis
    • Growing demand for personalized medicine driving the need for efficient DNA testing kits
  • Market Restraints
    • The need for highly specialized equipment and skilled personnel increases operational expenses for blood DNA kit manufacturers
  • Market Opportunities
    • Rising prevalence of genetic disorders and cancers spurring the adoption of blood DNA kits
    • Growing awareness about preventive healthcare encouraging consumers to use blood DNA kits
    • Expanding applications of blood DNA testing in ancestry and genealogy research increasing market demand
  • Market Challenges
    • Variability in sample quality and collection methods can lead to inconsistent and unreliable test results, impacting market growth

Porter's Five Forces: A Strategic Tool for Navigating the Blood DNA Kit Market

Porter's five forces framework is a critical tool for understanding the competitive landscape of the Blood DNA Kit Market. It offers business organizations with a clear methodology for evaluating their competitive positioning and exploring strategic opportunities. This framework helps businesses assess the power dynamics within the market and determine the profitability of new ventures. With these insights, business organizations can leverage their strengths, address weaknesses, and avoid potential challenges, ensuring a more resilient market positioning.

PESTLE Analysis: Navigating External Influences in the Blood DNA Kit Market

External macro-environmental factors play a pivotal role in shaping the performance dynamics of the Blood DNA Kit Market. Political, Economic, Social, Technological, Legal, and Environmental factors analysis provides the necessary information to navigate these influences. By examining PESTLE factors, businesses can better understand potential risks and opportunities. This analysis enables business organizations to anticipate changes in regulations, consumer preferences, and economic trends, ensuring they are prepared to make proactive, forward-thinking decisions.

Market Share Analysis: Understanding the Competitive Landscape in the Blood DNA Kit Market

A detailed market share analysis in the Blood DNA Kit Market provides a comprehensive assessment of vendors' performance. Companies can identify their competitive positioning by comparing key metrics, including revenue, customer base, and growth rates. This analysis highlights market concentration, fragmentation, and trends in consolidation, offering vendors the insights required to make strategic decisions that enhance their position in an increasingly competitive landscape.

FPNV Positioning Matrix: Evaluating Vendors' Performance in the Blood DNA Kit Market

The Forefront, Pathfinder, Niche, Vital (FPNV) Positioning Matrix is a critical tool for evaluating vendors within the Blood DNA Kit Market. This matrix enables business organizations to make well-informed decisions that align with their goals by assessing vendors based on their business strategy and product satisfaction. The four quadrants provide a clear and precise segmentation of vendors, helping users identify the right partners and solutions that best fit their strategic objectives.

Strategy Analysis & Recommendation: Charting a Path to Success in the Blood DNA Kit Market

A strategic analysis of the Blood DNA Kit Market is essential for businesses looking to strengthen their global market presence. By reviewing key resources, capabilities, and performance indicators, business organizations can identify growth opportunities and work toward improvement. This approach helps businesses navigate challenges in the competitive landscape and ensures they are well-positioned to capitalize on newer opportunities and drive long-term success.

Key Company Profiles

The report delves into recent significant developments in the Blood DNA Kit Market, highlighting leading vendors and their innovative profiles. These include 23andMe Inc., Ancestry.com LLC, Color Genomics Inc., Dante Labs, DNAfit, EasyDNA, Embark Veterinary Inc., FamilyTreeDNA, Futura Genetics, GenoPalate Inc., Genos Inc., Helix OpCo LLC, Living DNA Ltd., Mapmygenome India Ltd., MyHeritage Ltd., Nebula Genomics, Orig3n Inc., Pathway Genomics Corporation, Veritas Genetics Inc., and Xcode Life Sciences.

Market Segmentation & Coverage

This research report categorizes the Blood DNA Kit Market to forecast the revenues and analyze trends in each of the following sub-markets:

  • Based on Technology, market is studied across Next-Generation Sequencing and Polymerase Chain Reaction.
  • Based on End User, market is studied across Hospital and Clinics and Research Centers.
  • Based on Region, market is studied across Americas, Asia-Pacific, and Europe, Middle East & Africa. The Americas is further studied across Argentina, Brazil, Canada, Mexico, and United States. The United States is further studied across California, Florida, Illinois, New York, Ohio, Pennsylvania, and Texas. The Asia-Pacific is further studied across Australia, China, India, Indonesia, Japan, Malaysia, Philippines, Singapore, South Korea, Taiwan, Thailand, and Vietnam. The Europe, Middle East & Africa is further studied across Denmark, Egypt, Finland, France, Germany, Israel, Italy, Netherlands, Nigeria, Norway, Poland, Qatar, Russia, Saudi Arabia, South Africa, Spain, Sweden, Switzerland, Turkey, United Arab Emirates, and United Kingdom.

The report offers a comprehensive analysis of the market, covering key focus areas:

1. Market Penetration: A detailed review of the current market environment, including extensive data from top industry players, evaluating their market reach and overall influence.

2. Market Development: Identifies growth opportunities in emerging markets and assesses expansion potential in established sectors, providing a strategic roadmap for future growth.

3. Market Diversification: Analyzes recent product launches, untapped geographic regions, major industry advancements, and strategic investments reshaping the market.

4. Competitive Assessment & Intelligence: Provides a thorough analysis of the competitive landscape, examining market share, business strategies, product portfolios, certifications, regulatory approvals, patent trends, and technological advancements of key players.

5. Product Development & Innovation: Highlights cutting-edge technologies, R&D activities, and product innovations expected to drive future market growth.

The report also answers critical questions to aid stakeholders in making informed decisions:

1. What is the current market size, and what is the forecasted growth?

2. Which products, segments, and regions offer the best investment opportunities?

3. What are the key technology trends and regulatory influences shaping the market?

4. How do leading vendors rank in terms of market share and competitive positioning?

5. What revenue sources and strategic opportunities drive vendors' market entry or exit strategies?

Table of Contents

1. Preface

  • 1.1. Objectives of the Study
  • 1.2. Market Segmentation & Coverage
  • 1.3. Years Considered for the Study
  • 1.4. Currency & Pricing
  • 1.5. Language
  • 1.6. Stakeholders

2. Research Methodology

  • 2.1. Define: Research Objective
  • 2.2. Determine: Research Design
  • 2.3. Prepare: Research Instrument
  • 2.4. Collect: Data Source
  • 2.5. Analyze: Data Interpretation
  • 2.6. Formulate: Data Verification
  • 2.7. Publish: Research Report
  • 2.8. Repeat: Report Update

3. Executive Summary

4. Market Overview

5. Market Insights

  • 5.1. Market Dynamics
    • 5.1.1. Drivers
      • 5.1.1.1. Increased adoption of blood DNA kits by clinical laboratories for diagnostic purposes
      • 5.1.1.2. Advancements in genomics and related technologies enhancing blood DNA kit accuracy
      • 5.1.1.3. Rising prevalence of genetic disorders and chronic diseases necessitating early diagnosis
      • 5.1.1.4. Growing demand for personalized medicine driving the need for efficient DNA testing kits
    • 5.1.2. Restraints
      • 5.1.2.1. The need for highly specialized equipment and skilled personnel increases operational expenses for blood DNA kit manufacturers
    • 5.1.3. Opportunities
      • 5.1.3.1. Rising prevalence of genetic disorders and cancers spurring the adoption of blood DNA kits
      • 5.1.3.2. Growing awareness about preventive healthcare encouraging consumers to use blood DNA kits
      • 5.1.3.3. Expanding applications of blood DNA testing in ancestry and genealogy research increasing market demand
    • 5.1.4. Challenges
      • 5.1.4.1. Variability in sample quality and collection methods can lead to inconsistent and unreliable test results, impacting market growth
  • 5.2. Market Segmentation Analysis
  • 5.3. Porter's Five Forces Analysis
    • 5.3.1. Threat of New Entrants
    • 5.3.2. Threat of Substitutes
    • 5.3.3. Bargaining Power of Customers
    • 5.3.4. Bargaining Power of Suppliers
    • 5.3.5. Industry Rivalry
  • 5.4. PESTLE Analysis
    • 5.4.1. Political
    • 5.4.2. Economic
    • 5.4.3. Social
    • 5.4.4. Technological
    • 5.4.5. Legal
    • 5.4.6. Environmental

6. Blood DNA Kit Market, by Technology

  • 6.1. Introduction
  • 6.2. Next-Generation Sequencing
  • 6.3. Polymerase Chain Reaction

7. Blood DNA Kit Market, by End User

  • 7.1. Introduction
  • 7.2. Hospital and Clinics
  • 7.3. Research Centers

8. Americas Blood DNA Kit Market

  • 8.1. Introduction
  • 8.2. Argentina
  • 8.3. Brazil
  • 8.4. Canada
  • 8.5. Mexico
  • 8.6. United States

9. Asia-Pacific Blood DNA Kit Market

  • 9.1. Introduction
  • 9.2. Australia
  • 9.3. China
  • 9.4. India
  • 9.5. Indonesia
  • 9.6. Japan
  • 9.7. Malaysia
  • 9.8. Philippines
  • 9.9. Singapore
  • 9.10. South Korea
  • 9.11. Taiwan
  • 9.12. Thailand
  • 9.13. Vietnam

10. Europe, Middle East & Africa Blood DNA Kit Market

  • 10.1. Introduction
  • 10.2. Denmark
  • 10.3. Egypt
  • 10.4. Finland
  • 10.5. France
  • 10.6. Germany
  • 10.7. Israel
  • 10.8. Italy
  • 10.9. Netherlands
  • 10.10. Nigeria
  • 10.11. Norway
  • 10.12. Poland
  • 10.13. Qatar
  • 10.14. Russia
  • 10.15. Saudi Arabia
  • 10.16. South Africa
  • 10.17. Spain
  • 10.18. Sweden
  • 10.19. Switzerland
  • 10.20. Turkey
  • 10.21. United Arab Emirates
  • 10.22. United Kingdom

11. Competitive Landscape

  • 11.1. Market Share Analysis, 2023
  • 11.2. FPNV Positioning Matrix, 2023
  • 11.3. Competitive Scenario Analysis
  • 11.4. Strategy Analysis & Recommendation

Companies Mentioned

  • 1. 23andMe Inc.
  • 2. Ancestry.com LLC
  • 3. Color Genomics Inc.
  • 4. Dante Labs
  • 5. DNAfit
  • 6. EasyDNA
  • 7. Embark Veterinary Inc.
  • 8. FamilyTreeDNA
  • 9. Futura Genetics
  • 10. GenoPalate Inc.
  • 11. Genos Inc.
  • 12. Helix OpCo LLC
  • 13. Living DNA Ltd.
  • 14. Mapmygenome India Ltd.
  • 15. MyHeritage Ltd.
  • 16. Nebula Genomics
  • 17. Orig3n Inc.
  • 18. Pathway Genomics Corporation
  • 19. Veritas Genetics Inc.
  • 20. Xcode Life Sciences

LIST OF FIGURES

  • FIGURE 1. BLOOD DNA KIT MARKET RESEARCH PROCESS
  • FIGURE 2. BLOOD DNA KIT MARKET SIZE, 2023 VS 2030
  • FIGURE 3. GLOBAL BLOOD DNA KIT MARKET SIZE, 2018-2030 (USD MILLION)
  • FIGURE 4. GLOBAL BLOOD DNA KIT MARKET SIZE, BY REGION, 2023 VS 2024 VS 2030 (USD MILLION)
  • FIGURE 5. GLOBAL BLOOD DNA KIT MARKET SIZE, BY COUNTRY, 2023 VS 2024 VS 2030 (USD MILLION)
  • FIGURE 6. GLOBAL BLOOD DNA KIT MARKET SIZE, BY TECHNOLOGY, 2023 VS 2030 (%)
  • FIGURE 7. GLOBAL BLOOD DNA KIT MARKET SIZE, BY TECHNOLOGY, 2023 VS 2024 VS 2030 (USD MILLION)
  • FIGURE 8. GLOBAL BLOOD DNA KIT MARKET SIZE, BY END USER, 2023 VS 2030 (%)
  • FIGURE 9. GLOBAL BLOOD DNA KIT MARKET SIZE, BY END USER, 2023 VS 2024 VS 2030 (USD MILLION)
  • FIGURE 10. AMERICAS BLOOD DNA KIT MARKET SIZE, BY COUNTRY, 2023 VS 2030 (%)
  • FIGURE 11. AMERICAS BLOOD DNA KIT MARKET SIZE, BY COUNTRY, 2023 VS 2024 VS 2030 (USD MILLION)
  • FIGURE 12. UNITED STATES BLOOD DNA KIT MARKET SIZE, BY STATE, 2023 VS 2030 (%)
  • FIGURE 13. UNITED STATES BLOOD DNA KIT MARKET SIZE, BY STATE, 2023 VS 2024 VS 2030 (USD MILLION)
  • FIGURE 14. ASIA-PACIFIC BLOOD DNA KIT MARKET SIZE, BY COUNTRY, 2023 VS 2030 (%)
  • FIGURE 15. ASIA-PACIFIC BLOOD DNA KIT MARKET SIZE, BY COUNTRY, 2023 VS 2024 VS 2030 (USD MILLION)
  • FIGURE 16. EUROPE, MIDDLE EAST & AFRICA BLOOD DNA KIT MARKET SIZE, BY COUNTRY, 2023 VS 2030 (%)
  • FIGURE 17. EUROPE, MIDDLE EAST & AFRICA BLOOD DNA KIT MARKET SIZE, BY COUNTRY, 2023 VS 2024 VS 2030 (USD MILLION)
  • FIGURE 18. BLOOD DNA KIT MARKET SHARE, BY KEY PLAYER, 2023
  • FIGURE 19. BLOOD DNA KIT MARKET, FPNV POSITIONING MATRIX, 2023

LIST OF TABLES

  • TABLE 1. BLOOD DNA KIT MARKET SEGMENTATION & COVERAGE
  • TABLE 2. UNITED STATES DOLLAR EXCHANGE RATE, 2018-2023
  • TABLE 3. GLOBAL BLOOD DNA KIT MARKET SIZE, 2018-2030 (USD MILLION)
  • TABLE 4. GLOBAL BLOOD DNA KIT MARKET SIZE, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 5. GLOBAL BLOOD DNA KIT MARKET SIZE, BY COUNTRY, 2018-2030 (USD MILLION)
  • TABLE 6. BLOOD DNA KIT MARKET DYNAMICS
  • TABLE 7. GLOBAL BLOOD DNA KIT MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
  • TABLE 8. GLOBAL BLOOD DNA KIT MARKET SIZE, BY NEXT-GENERATION SEQUENCING, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 9. GLOBAL BLOOD DNA KIT MARKET SIZE, BY POLYMERASE CHAIN REACTION, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 10. GLOBAL BLOOD DNA KIT MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
  • TABLE 11. GLOBAL BLOOD DNA KIT MARKET SIZE, BY HOSPITAL AND CLINICS, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 12. GLOBAL BLOOD DNA KIT MARKET SIZE, BY RESEARCH CENTERS, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 13. AMERICAS BLOOD DNA KIT MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
  • TABLE 14. AMERICAS BLOOD DNA KIT MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
  • TABLE 15. AMERICAS BLOOD DNA KIT MARKET SIZE, BY COUNTRY, 2018-2030 (USD MILLION)
  • TABLE 16. ARGENTINA BLOOD DNA KIT MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
  • TABLE 17. ARGENTINA BLOOD DNA KIT MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
  • TABLE 18. BRAZIL BLOOD DNA KIT MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
  • TABLE 19. BRAZIL BLOOD DNA KIT MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
  • TABLE 20. CANADA BLOOD DNA KIT MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
  • TABLE 21. CANADA BLOOD DNA KIT MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
  • TABLE 22. MEXICO BLOOD DNA KIT MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
  • TABLE 23. MEXICO BLOOD DNA KIT MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
  • TABLE 24. UNITED STATES BLOOD DNA KIT MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
  • TABLE 25. UNITED STATES BLOOD DNA KIT MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
  • TABLE 26. UNITED STATES BLOOD DNA KIT MARKET SIZE, BY STATE, 2018-2030 (USD MILLION)
  • TABLE 27. ASIA-PACIFIC BLOOD DNA KIT MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
  • TABLE 28. ASIA-PACIFIC BLOOD DNA KIT MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
  • TABLE 29. ASIA-PACIFIC BLOOD DNA KIT MARKET SIZE, BY COUNTRY, 2018-2030 (USD MILLION)
  • TABLE 30. AUSTRALIA BLOOD DNA KIT MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
  • TABLE 31. AUSTRALIA BLOOD DNA KIT MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
  • TABLE 32. CHINA BLOOD DNA KIT MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
  • TABLE 33. CHINA BLOOD DNA KIT MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
  • TABLE 34. INDIA BLOOD DNA KIT MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
  • TABLE 35. INDIA BLOOD DNA KIT MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
  • TABLE 36. INDONESIA BLOOD DNA KIT MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
  • TABLE 37. INDONESIA BLOOD DNA KIT MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
  • TABLE 38. JAPAN BLOOD DNA KIT MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
  • TABLE 39. JAPAN BLOOD DNA KIT MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
  • TABLE 40. MALAYSIA BLOOD DNA KIT MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
  • TABLE 41. MALAYSIA BLOOD DNA KIT MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
  • TABLE 42. PHILIPPINES BLOOD DNA KIT MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
  • TABLE 43. PHILIPPINES BLOOD DNA KIT MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
  • TABLE 44. SINGAPORE BLOOD DNA KIT MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
  • TABLE 45. SINGAPORE BLOOD DNA KIT MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
  • TABLE 46. SOUTH KOREA BLOOD DNA KIT MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
  • TABLE 47. SOUTH KOREA BLOOD DNA KIT MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
  • TABLE 48. TAIWAN BLOOD DNA KIT MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
  • TABLE 49. TAIWAN BLOOD DNA KIT MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
  • TABLE 50. THAILAND BLOOD DNA KIT MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
  • TABLE 51. THAILAND BLOOD DNA KIT MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
  • TABLE 52. VIETNAM BLOOD DNA KIT MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
  • TABLE 53. VIETNAM BLOOD DNA KIT MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
  • TABLE 54. EUROPE, MIDDLE EAST & AFRICA BLOOD DNA KIT MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
  • TABLE 55. EUROPE, MIDDLE EAST & AFRICA BLOOD DNA KIT MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
  • TABLE 56. EUROPE, MIDDLE EAST & AFRICA BLOOD DNA KIT MARKET SIZE, BY COUNTRY, 2018-2030 (USD MILLION)
  • TABLE 57. DENMARK BLOOD DNA KIT MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
  • TABLE 58. DENMARK BLOOD DNA KIT MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
  • TABLE 59. EGYPT BLOOD DNA KIT MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
  • TABLE 60. EGYPT BLOOD DNA KIT MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
  • TABLE 61. FINLAND BLOOD DNA KIT MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
  • TABLE 62. FINLAND BLOOD DNA KIT MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
  • TABLE 63. FRANCE BLOOD DNA KIT MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
  • TABLE 64. FRANCE BLOOD DNA KIT MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
  • TABLE 65. GERMANY BLOOD DNA KIT MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
  • TABLE 66. GERMANY BLOOD DNA KIT MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
  • TABLE 67. ISRAEL BLOOD DNA KIT MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
  • TABLE 68. ISRAEL BLOOD DNA KIT MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
  • TABLE 69. ITALY BLOOD DNA KIT MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
  • TABLE 70. ITALY BLOOD DNA KIT MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
  • TABLE 71. NETHERLANDS BLOOD DNA KIT MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
  • TABLE 72. NETHERLANDS BLOOD DNA KIT MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
  • TABLE 73. NIGERIA BLOOD DNA KIT MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
  • TABLE 74. NIGERIA BLOOD DNA KIT MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
  • TABLE 75. NORWAY BLOOD DNA KIT MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
  • TABLE 76. NORWAY BLOOD DNA KIT MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
  • TABLE 77. POLAND BLOOD DNA KIT MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
  • TABLE 78. POLAND BLOOD DNA KIT MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
  • TABLE 79. QATAR BLOOD DNA KIT MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
  • TABLE 80. QATAR BLOOD DNA KIT MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
  • TABLE 81. RUSSIA BLOOD DNA KIT MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
  • TABLE 82. RUSSIA BLOOD DNA KIT MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
  • TABLE 83. SAUDI ARABIA BLOOD DNA KIT MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
  • TABLE 84. SAUDI ARABIA BLOOD DNA KIT MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
  • TABLE 85. SOUTH AFRICA BLOOD DNA KIT MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
  • TABLE 86. SOUTH AFRICA BLOOD DNA KIT MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
  • TABLE 87. SPAIN BLOOD DNA KIT MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
  • TABLE 88. SPAIN BLOOD DNA KIT MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
  • TABLE 89. SWEDEN BLOOD DNA KIT MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
  • TABLE 90. SWEDEN BLOOD DNA KIT MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
  • TABLE 91. SWITZERLAND BLOOD DNA KIT MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
  • TABLE 92. SWITZERLAND BLOOD DNA KIT MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
  • TABLE 93. TURKEY BLOOD DNA KIT MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
  • TABLE 94. TURKEY BLOOD DNA KIT MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
  • TABLE 95. UNITED ARAB EMIRATES BLOOD DNA KIT MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
  • TABLE 96. UNITED ARAB EMIRATES BLOOD DNA KIT MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
  • TABLE 97. UNITED KINGDOM BLOOD DNA KIT MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
  • TABLE 98. UNITED KINGDOM BLOOD DNA KIT MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
  • TABLE 99. BLOOD DNA KIT MARKET SHARE, BY KEY PLAYER, 2023
  • TABLE 100. BLOOD DNA KIT MARKET, FPNV POSITIONING MATRIX, 2023